SMART Exercise for PAD
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for Peripheral Artery Disease: The SMART PAD Trial
1 other identifier
interventional
210
1 country
3
Brief Summary
Supervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for people disabled by lower extremity peripheral artery disease (PAD). However, travelling three times/week to a center for SET is burdensome. Compared to SET, home-based exercise is more accessible and less burdensome. Yet, evidence-based guidelines recommend SET over home-based exercise for PAD. Walking exercise is first line therapy to improve walking distance for PAD, but it does not eliminate ischemic leg symptoms in most people with PAD. The investigators' work and that of others showed that nitrate-rich beetroot juice, which increases plasma nitrite, limb perfusion, and skeletal muscle function, significantly improved exercise tolerance and reduced non-response to exercise in people with and without PAD. The investigators will use a 2 x 2 factorial design to address two major barriers to achieving benefits from exercise therapy for PAD: First, guideline recommendations for supervised exercise therapy (SET) as first line therapy for PAD. Second, the inability of exercise therapy to eliminate PAD-related disability in most people with PAD. Participants will be randomized to one of four groups for 12 weeks: Supervised treadmill exercise + nitrate rich beetroot juice; supervised treadmill exercise + placebo, home-based walking exercise + nitrate rich beetroot juice, home-based walking exercise + placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Sep 2023
Longer than P75 for phase_3
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2023
CompletedStudy Start
First participant enrolled
September 8, 2023
CompletedFirst Posted
Study publicly available on registry
September 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2029
April 15, 2026
April 1, 2026
5.2 years
May 22, 2023
April 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Six-Minute Walk Distance
Change in six-minute walk distance
Measured at baseline and 12 week follow-up
Secondary Outcomes (5)
Walking Impairment Questionnaire (WIQ) Distance Score
measured at baseline and 12 weeks
PROMIS Mobility Questionnaire Score
measured at baseline and 12 weeks
20-meter Improvement in Six-Minute Walk Distance
measured at 12 weeks
Step Count
measured at baseline and 12 weeks
Six-Minute Walk Distance
Measured at baseline and 24-week follow up
Other Outcomes (9)
Physical Activity Step Count
Measured at baseline and 24 weeks
Physical activity distance
Measured at baseline and 24 weeks.
Short physical performance battery (SPPB)
measured at baseline and 12 weeks
- +6 more other outcomes
Study Arms (4)
Supervised treadmill exercise + nitrate rich beetroot juice
EXPERIMENTALThis group will be participating in Supervised Treadmill Exercise and drinking nitrate rich beetroot juice for 12 weeks.
Supervised treadmill exercise + placebo
PLACEBO COMPARATORThis group will be participating in Supervised Treadmill Exercise and drinking placebo beetroot juice with nitrate removed for 12 weeks.
Home-based walking exercise + nitrate rich beetroot juice
EXPERIMENTALThis group will be participating in Home-Based Exercise and drinking nitrate rich beetroot juice for 12 weeks.
Home-based walking exercise + placebo
PLACEBO COMPARATORThis group will be participating in Home-Based Exercise and drinking placebo beetroot juice with nitrated removed for 12 weeks.
Interventions
This is a 12 week intervention where participants will walk for exercise 3 times a week on a treadmill at a center while being supervised by healthcare personnel.
This is a 12 week intervention where participants will walk at home for exercise with guidance from a study coach. They will have 4 in person visits in the first four weeks and then have weekly phone calls in the last 8 weeks of the intervention with their coach.
Participants will drink one shot of nitrate rich beet-root juice twice daily for 12 weeks.
Eligibility Criteria
You may qualify if:
- First, all participants will be age 50 and older. Second, all participants will have PAD. PAD will be defined as either:
- An ABI \<= 0.90 at baseline.
- Vascular lab evidence of PAD (such as a toe brachial pressure less than or equal to 0.70 or an ankle brachial index less than or equal to 0.90), or angiographic evidence of PAD defined as at least 70% stenosis of an artery supplying the lower extremities.
- An ABI of \>0.90 and \<1.00 who experience a 20% or greater drop in ABI in either leg after the heel-rise test.
You may not qualify if:
- Above- or below-knee amputation
- Limb-threatening ischemia defined as an ABI \<0.40 with symptoms of rest pain
- Wheelchair confinement or requiring a walker to ambulate
- Walking is limited by a condition other than PAD
- Current foot ulcer on bottom of foot
- Unwilling to drink beetroot juice
- Unwilling to accept randomization into either group (home based exercise or supervised exercise)
- Planning to engage in new walking exercise outside of the study or unwilling to refrain from new walking exercise activity during the trial.
- Already exercising at a level consistent with exercise intervention.
- End-stage kidney disease (ESKD) associated with the need for dialysis.
- Planned major surgery, coronary or leg revascularization during the next six months
- Major surgery, coronary or leg revascularization or major cardiovascular event in the previous three months
- Major medical illness including lung disease requiring oxygen, Parkinson's disease, a life-threatening illness with life expectancy less than six months, or cancer requiring treatment in the previous two years. \[NOTE: potential participants may still qualify if they have had treatment for an early stage cancer in the past two years and the prognosis is excellent. Participants who require oxygen only at night may still qualify.\]
- Mini-Mental Status Examination (MMSE) score \< 23 or dementia. However, if the MMSE is \< 23 and the Principal Investigator evaluation determines that the lower score is related to language barriers or education level, the Principal Investigator has discretion to allow a participant with MMSE \< 23 to participate, as appropriate.
- Allergy to beetroot juice
- +12 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Northwestern University Feinberg School of Medicine
Chicago, Illinois, 60611, United States
University of Chicago
Chicago, Illinois, 60637, United States
University of Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- For the beetroot juice vs. placebo comparison, this will be a double blinded study where both the participant and the people collecting data will be blinded. For the supervised exercise vs. home-based exercise comparison, the participant and investigator will not be blinded, but the outcomes assessor will be blinded.
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Jeremiah Stamler Professor of Medicine
Study Record Dates
First Submitted
May 22, 2023
First Posted
September 11, 2023
Study Start
September 8, 2023
Primary Completion (Estimated)
November 1, 2028
Study Completion (Estimated)
March 31, 2029
Last Updated
April 15, 2026
Record last verified: 2026-04